Since numerous studies have impressively demonstrated the influence of personality traits on financial decision making, the question arises if genetic biological markers might underlie this association. The present study investigated exploratively the relationship between financial decision-making behavior and genetic markers of the dopaminergic system, as dopamine has already proved to be a promising candidate for risk-taking and decision-making behavior. Therefore, a stock market simulation was performed over the course of 3 weeks with N = 133 (60 females, 73 males) participants. All of them were genotyped for the functional gene polymorphisms dopamine transporter variable number of tandem repeats (VNTR) polymorphism (rs28363170), COMTVal158Met (rs4680), DRD 2 /ANKK1 Taq1A (rs1800497), and a dopamine D 4 receptor VNTR in exon 3 (DRD 4 e3). Genotypes were used to calculate a polygenic score (PGS), which could explain around 21% of the variance in the outcome at the end of the stock market simulation (Capital). Here, sex-dependent effects were evident, showing that the polymorphisms and the PGS only affected the outcome in male participants. This sex difference might have various causes, including different socialization processes, which should be investigated further in future studies. Furthermore, by means of the PGS, we extended a previously published model, which ultimately resulted in a variance explanation of 49% regarding Capital. Herewith, we offer a comprehensive model for the success within the stock market game simulation and provide yet another evidence of the relevance of dopamine for decision-making processes, also within financial contexts.